Successful use of recombinant factor VIIa in pelvic fracture haemorrhage.
Recombinant factor VIIa is a novel haemostatic agent and was originally developed to treat haemophilia patients. Successful use of the factor in a 30-year-old male patient with pelvic fracture haemorrhage is being described by the authors.
Dhruva
Kumar K
KK
Medical Trust Hospital, Cochin, Kerala 682016.
Joel
V D
VD
Antony
S
S
Vinodan
K
K
D000328:Adult; D005167:Factor VII / Q000627:therapeutic use*; D015942:Factor VIIa; D050723:Fractures, Bone / Q000150:complications*; D006470:Hemorrhage / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D008297:Male; D010384:Pelvic Bones / Q000293:injuries*; D011994:Recombinant Proteins / Q000627:therapeutic use
D011994:Recombinant Proteins; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa